WinstonWınston
Back
Definitive Healthcare logo

Definitive Healthcare

DH
46
Medical - Healthcare Information Services · Healthcare
Price
$0.71
-0.01 (-1.84%)
Market Cap
$75.4M
Exchange
NASDAQ
Winston Score
46
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Mixed
Cash Flow
Mixed
Stability
Good
Valuation
Data not available

Share count rising — dilution

+9.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 97.0M (2021) → 106.7M (2025)

Winston Score History

The full picture

Definitive Healthcare sells data and analytics about the healthcare industry. Its platform gives companies detailed information about hospitals, doctors, clinics, and other healthcare providers — like how many patients they see, what technologies they use, and how they spend money. The main customers are businesses that sell products or services to healthcare providers, such as medical device companies, pharmaceutical firms, and health IT vendors.

The company makes money through annual software subscriptions, giving customers ongoing access to its database and analytics tools. It operates primarily in the United States, where its large and regularly updated dataset of healthcare provider information acts as its main competitive advantage — building that kind of database takes years and significant resources. The key risk is that the company faces growing competition from other healthcare data providers and must keep its data accurate and comprehensive enough to justify renewal from customers, especially as its market cap has fallen sharply from its 2021 IPO highs.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-9.1% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+29.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$35M/ year

Flat (-5% vs prior year)

14.4% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

71.9%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$184M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Definitive Healthcare's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
73.5%
Premium pricing power — 73.5% gross margin
Profit after running costs
Operating Margin
-12.2%
Losing money on operations — -12.2%
Return on the money invested
ROCE
51.4%
Exceptional — 51.4% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-5.0%
Shrinking sales (-5.0% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
12.3%
Converts sales into free cash efficiently (12.3%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
1.11
Elevated debt (1.11)
Covers its interest
Interest Cover
14.10x
Comfortably covers interest (14.1x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial